- Trials with a EudraCT protocol (28)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28 result(s) found for: Nerve Conduction Studies.
Displaying page 1 of 2.
EudraCT Number: 2012-001246-17 | Sponsor Protocol Number: CBX129801-DN-201 | Start Date*: 2013-05-28 |
Sponsor Name:Cebix Incorporated | ||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of CBX129801 (Ersatta™), Long-Acting Synthetic C-Peptide, in Type 1 Diabetes Mellitus Subjects wit... | ||
Medical condition: Mild to moderate diabetic peripheral neuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001871-31 | Sponsor Protocol Number: 4076 | Start Date*: 2008-09-04 | ||||||||||||||||
Sponsor Name:Region skåne- Hässleholms sjukvårdsorganisation | ||||||||||||||||||
Full Title: Local steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment | ||||||||||||||||||
Medical condition: Neurography verified Carpal tunnel syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000557-35 | Sponsor Protocol Number: NW-1029/001/II/2003 | Start Date*: 2005-06-09 |
Sponsor Name:Newron Pharmaceuticals SpA | ||
Full Title: A phase II, multi centre, pilot, randomised, ascending dose, double -blind, placebo controlled, dose titration study to determine the safety, maximum tolerated dose and preliminary evidence of effi... | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003046-33 | Sponsor Protocol Number: kepp2 | Start Date*: 2005-09-02 |
Sponsor Name:Søren H. Sindrup, Department of Neurology, Odense University Hospital | ||
Full Title: Double-bllind, randomised, placebo-controlled trial of levetiracetam in painful polyneuropathy | ||
Medical condition: Painful polyneuropathy (idiopathic, diabetic, alcoholic, drug-induced and other etiologies) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000828-28 | Sponsor Protocol Number: 52642 | Start Date*: 2016-07-26 |
Sponsor Name:UMC Utrecht | ||
Full Title: Titlle: Subcutaneous immunoglobulins with rHuPH20 in multifocal motor neuropathy (MMN) It is an interventional cross-over study where the use of the combination of subcutaneous immunoglobulins ... | ||
Medical condition: Non-inferiority and safety/tolerance of Hyqvia compared to IVIg in 20 MMN patients with at least one conduction block on EMG and stable on IVIg. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004833-40 | Sponsor Protocol Number: EFC10518 | Start Date*: 2008-05-14 | |||||||||||
Sponsor Name:sanofi-aventis recherche & developpement | |||||||||||||
Full Title: A randomized, double blind, placebo controlled study evaluating the glycemic effect of rimonabant added to metformin in patients with type 2 diabetes insufficiently controlled with metformin monoth... | |||||||||||||
Medical condition: Type 2 Diabetes patients insufficiently controlled with metformin monotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003453-18 | Sponsor Protocol Number: RH-2015-200 | Start Date*: 2015-11-25 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: A Randomized, Single-blinded, Cross-over Study investigating the Non-inferiority of Efficacy and Safety of HyQvia in comparison with Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropa... | |||||||||||||
Medical condition: Multifocal Motor Neuropathy (MMN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002378-19 | Sponsor Protocol Number: CLN-PXT3003-02 | Start Date*: 2015-08-27 | |||||||||||
Sponsor Name:PHARNEXT | |||||||||||||
Full Title: International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-T... | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease - Type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Suspended by CA) ES (Completed) BE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013642-80 | Sponsor Protocol Number: TCAPGB | Start Date*: 2009-09-30 | |||||||||||
Sponsor Name:Department of Neurology, Odense University Hospital | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled trial of the effect of the combination of imipramine and pregabalin for the treatment of painful polyneuropathy | |||||||||||||
Medical condition: Painful polyneuropathy (idiopathic, diabetic, alcoholic, drug-induced and other etiologies) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000821-37 | Sponsor Protocol Number: O3NPIQ | Start Date*: 2019-12-10 | |||||||||||
Sponsor Name:Bernardino Clavo - Hospital Universitario de G. C. Dr. Negrín | |||||||||||||
Full Title: Effectiveness and cost-effectiveness of Ozone therapy in patients with pain secondary to chemotherapy-induced peripheral neuropathy. Randomized, triple-blind clinical trial. | |||||||||||||
Medical condition: Pain secondary to chemotherapy-induced peripheral neuropathy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001340-25 | Sponsor Protocol Number: UMC-NMZ-EPHENE2020 | Start Date*: 2020-07-17 | |||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||
Full Title: Enrichment randomized double-blind, placebo-controlled cross-over trial with PHEnytoin cream in patients with painful chronic idiopathic axonal polyNEuropathy | |||||||||||||
Medical condition: Painful chronic idiopathic axonal polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002044-28 | Sponsor Protocol Number: HGT-MLD-070 | Start Date*: 2012-06-14 | |||||||||||
Sponsor Name:Shire Human Genetics Therapies Inc | |||||||||||||
Full Title: A Phase I/II, Multicenter, Open-label, Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy | |||||||||||||
Medical condition: Treatment of Metachromatic Leukodystrophy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000698-38 | Sponsor Protocol Number: MD1003CT2014-01AMN | Start Date*: 2014-08-13 | |||||||||||
Sponsor Name:MEDDAY SAS | |||||||||||||
Full Title: MD1003 IN ADRENOMYELONEUROPATHY: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY | |||||||||||||
Medical condition: Adrenomyeloneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005229-95 | Sponsor Protocol Number: PBKR03-001 | Start Date*: 2021-08-23 | |||||||||||
Sponsor Name:Passage Bio, Inc. | |||||||||||||
Full Title: A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects with Early Infantile Krabbe Dis... | |||||||||||||
Medical condition: Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive lysosomal storage disease (LSD) caused by mutations in the gene encoding the hydrolytic enzyme galactosylceramidase (galactoce... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000009-25 | Sponsor Protocol Number: 19PH226 | Start Date*: 2021-04-12 | |||||||||||
Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
Full Title: Rituximab therapy in anti-MAG patients with characteristics of good responders: THERAMAG study | |||||||||||||
Medical condition: Anti-MAG neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004670-10 | Sponsor Protocol Number: AG10-333 | Start Date*: 2020-07-07 | |||||||||||
Sponsor Name:Eidos Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Polyneuropathy (ATTRibute-PN Trial) | |||||||||||||
Medical condition: Symptomatic Transthyretin Amyloid Polineuropathy (ATTR-PN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) PT (Prematurely Ended) FR (Completed) BG (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006791-12 | Sponsor Protocol Number: Fx1A-201 | Start Date*: 2008-04-02 |
Sponsor Name:FoldRx Pharmaceuticals Limited | ||
Full Title: The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients with Non-V30M Transthyretin Amyloidosis | ||
Medical condition: Non-V30M Transthyretin Amyloidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001109-22 | Sponsor Protocol Number: PBGM01-001 | Start Date*: Information not available in EudraCT |
Sponsor Name:Passage Bio, Inc. | ||
Full Title: A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered into the Cisterna Magna of Pediatric Su... | ||
Medical condition: GM1 gangliosidosis (GM1) is an autosomal recessive disorder that results from mutations in the human galactosidase beta 1 gene (GLB1), which encodes beta-galactosidase (β-gal). | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004371-36 | Sponsor Protocol Number: WS1798052 | Start Date*: 2011-11-15 |
Sponsor Name:Instituto de Investigaciones del Sueño | ||
Full Title: Effects of pregabalin on slow wave sleep and glucose tolerance in patients with diabetic polyneuropathy. An exploratory study. | ||
Medical condition: Patients with diabetic polyneuropathy (DPN) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.